ASPIRE BIOPHARMA HOLDIN-CW27 (ASBPW) Stock News
NASDAQ:ASBPW - Nasdaq - - Currency: USD
ASBPW Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - ACCESS Newswire
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21
Mentions: ASBP
a month ago - ACCESS Newswire
Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
Mentions: ASBP
a month ago - ACCESS Newswire
Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement
Mentions: ASBP
a month ago - ACCESS Newswire
Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Mentions: ASBP
2 months ago - ACCESS Newswire
Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement
Mentions: ASBP
3 months ago - ACCESS Newswire
Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin
Mentions: ASBP
2 months ago - ACCESS Newswire
Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform
Mentions: ASBP
3 months ago - ACCESS Newswire
Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement
Mentions: ASBP
3 months ago - ACCESS Newswire